Viewing Study NCT06851702

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2026-01-29 @ 1:27 AM
Study NCT ID: NCT06851702
Status: RECRUITING
Last Update Posted: 2025-02-28
First Post: 2025-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Observational Study for the Evaluation of Immune-mediated Endocrinological Adverse Events in Patients With Hematological Malignancies and Subjected to Treatment With Immune-checkpoint Inhibitors
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematological Malignancies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None immune-checkpoint inhibitors View
None endocrinological adverse events View